Buprenorphine Pharmacology Review: Update on Transmucosal and Long-acting Formulations

@article{Coe2019BuprenorphinePR,
  title={Buprenorphine Pharmacology Review: Update on Transmucosal and Long-acting Formulations},
  author={Marion A. Coe and M. Lofwall and S. Walsh},
  journal={Journal of Addiction Medicine},
  year={2019},
  volume={13},
  pages={93–103}
}
  • Marion A. Coe, M. Lofwall, S. Walsh
  • Published 2019
  • Medicine
  • Journal of Addiction Medicine
    • &NA; Buprenorphine is an effective treatment for opioid use disorder. As a high-affinity, partial agonist for the mu-opioid receptor, buprenorphine suppresses opioid withdrawal and craving, reduces illicit opioid use, and blocks exogenous opioid effects including respiratory depression. Other pharmacologic benefits of buprenorphine are its superior safety profile compared with full opioid agonists and its long half-life that allows daily or less-than-daily dosing. New and innovative… CONTINUE READING
    View on Wolters Kluwer
    ncbi.nlm.nih.gov
    17 Citations
    Highly Influencial Citations
    2
    Background Citations
    6

    Topics from this paper

    Explore Further: Topics Discussed in This Paper

    17 Citations
    Citation Type

    Citation Type

    Optimal dose of buprenorphine in opioid use disorder treatment: a review of pharmacodynamic and efficacy data
    • 3
    • Highly Influenced
    Novel Long-Acting Buprenorphine Medications for Opioid Dependence: Current Update.
    Buprenorphine implants: a model for expedited development and approval of new drugs.
    Impact of Pharmacological Treatments for Opioid Use Disorder on Mortality
    • 1
    Treating Perioperative and Acute Pain in Patients on Buprenorphine: Narrative Literature Review and Practice Recommendations
    Rapid Transition From Methadone to Buprenorphine Utilizing a Micro-dosing Protocol in the Outpatient Veteran Affairs Setting
    • 2
    • Highly Influenced
    Intravenous Buprenorphine Micro-dosing Induction in a Patient on Methadone Treatment: A Case Report
    Maternal buprenorphine treatment during pregnancy and maternal physiology.
    Pain management in opioid maintenance treatment
    • 2
    Diagnosis and Management of Opioid Use Disorder in Hospitalized Patients.

    References

    SHOWING 1-10 OF 49 REFERENCES
    Buprenorphine: clinical pharmacokinetics in the treatment of opioid dependence.
    • 208
    Human pharmacology and abuse potential of the analgesic buprenorphine: a potential agent for treating narcotic addiction.
    • 720
    Sustained-Release Buprenorphine (RBP-6000) Blocks the Effects of Opioid Challenge With Hydromorphone in Subjects With Opioid Use Disorder
    • 37
    Pharmacokinetics and pharmacodynamics of a buprenorphine subcutaneous depot formulation (CAM2038) for once-weekly dosing in patients with opioid use disorder.
    • 16
    Effect of Buprenorphine Weekly Depot (CAM2038) and Hydromorphone Blockade in Individuals With Opioid Use Disorder: A Randomized Clinical Trial
    • 31
    Pharmacokinetics of Buprenorphine: A Comparison of Sublingual Tablet Versus Liquid after Chronic Dosing
    • 9
    Buprenorphine: new pharmacological aspects.
    • A. Cowan
    • Medicine
    • International journal of clinical practice. Supplement
    • 2003
    • 89
    Buprenorphine: a (relatively) new treatment for opioid dependence.
    • 25
    Human pharmacokinetics of intravenous, sublingual, and buccal buprenorphine.
    • 221
    • PDF
    Buprenorphine implants for treatment of opioid dependence: a randomized controlled trial.
    • 119
    • Highly Influential
    • PDF